TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
SPS Pharma Solutions AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
462,517
|
425,701
|
407,559 |
| Financial expenses |
2,117
|
3,702
|
3,852 |
| Earnings before taxes |
45,973
|
-15,819
|
11,282 |
| EBITDA |
61,797
|
5,481
|
29,842 |
| Total assets |
455,811
|
427,874
|
365,505 |
| Current assets |
264,235
|
232,131
|
186,582 |
| Current liabilities |
120,432
|
145,964
|
129,459 |
| Equity capital |
297,006
|
270,121
|
220,953 |
| - share capital |
6,495
|
6,717
|
6,682 |
| Employees (average) |
306
|
322
|
312 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.2%
|
63.1%
|
60.5% |
| Turnover per employee |
1,511
|
1,322
|
1,306 |
| Profit as a percentage of turnover |
9.9%
|
-3.7%
|
2.8% |
| Return on assets (ROA) |
10.6%
|
-2.8%
|
4.1% |
| Current ratio |
219.4%
|
159.0%
|
144.1% |
| Return on equity (ROE) |
15.5%
|
-5.9%
|
5.1% |
| Change turnover |
50,896
|
16,044
|
88,236 |
| Change turnover % |
12%
|
4%
|
28% |
| Chg. No. of employees |
-16
|
10
|
34 |
| Chg. No. of employees % |
-5%
|
3%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.